# $xbi

Biotech sector sees mixed signals with positive M&A rumors and clinical trial successes countered by regulatory concerns and stock volatility. Investors remain cautiously optimistic about a potential bull run.

### About $xbi
XBI refers to the SPDR S&P Biotech ETF, a benchmark for the biotechnology sector.  

### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$xbi/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$xbi/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [-------]  
[--] Month: [---------] -55%  
[--] Months: [----------] +60%  
[--] Year: [----------] -20%  
1-Year High: [-------] on 2025-11-14  
1-Year Low: [------] on 2026-02-08  

Engagements by network (24h):
X: [------]
YouTube: [---]
Reddit: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$xbi/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$xbi/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
1-Year High: [-----] on 2025-11-24  
1-Year Low: [---] on 2025-09-15  

Mentions by network (24h):
X: [---]
YouTube: [--]
Reddit: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$xbi/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$xbi/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning $xbi in the last [--] hours which is down 17% from [---] in the previous [--] hours
Daily Average: [---]  
1-Year High: [---] on 2025-11-24  
1-Year Low: [--] on 2025-05-04  

The most influential creators that mention $xbi in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | [--]    | [------]    | [--]    | [-----]       |
| [@BOSSTRADING0](/creator/twitter/BOSSTRADING0)       | [--]    | [-----]     | [--]    | [-----]       |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]     | [-----]       |
| [@WassimLaroussi3](/creator/twitter/WassimLaroussi3) | [--]    | [-----]     | [--]     | [-----]       |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | [--]    | [------]    | [--]     | [-----]       |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]    | [-----]       |
| [@A_May_MD](/creator/twitter/A_May_MD)               | [--]    | [------]    | [--]     | [---]         |
| [@jfais20](/creator/twitter/jfais20)                 | [--]    | [------]    | [--]    | [---]         |
| [@yaireinhorn](/creator/twitter/yaireinhorn)         | [--]    | [------]    | [--]    | [---]         |
| [@crisprspace](/creator/twitter/crisprspace)         | [--]   | [---]       | [--]     | [---]         |

[View More](/list/creators/$xbi/100)

### Top $xbi Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"H.C. Wainwright $PRAX's PT to $1245 from $340 reiterated at Buy and said: $XBI Ulixacaltamide has been transformative but relutrigine is being overlooked and will drive significant value in our view; price target up to $1245. We're raising our peak sales estimates for both ulixacaltamide and relutrigine with our relutrigine estimate now far ahead of the Street with peak sales expectations of $6.8B. We think relutrgine is going to become a "workhouse" drug given to patients with a range of developmental epileptic encephalopathies. Right now investors are only looking at relutrigine in the"  
[X Link](https://x.com/Quantumup1/status/2017210185354276896) [@Quantumup1](/creator/x/Quantumup1) 2026-01-30T12:16Z [----] followers, [----] engagements


"970-uncertainty Fed head change $BTC $83k Gold.Silver.Copper.Natgas. consolidation Bitcoin crash 4.27% US 10y rate Euro/$ [----] Gold [----] WtiOil [--] SLV [---] Copper [----] $IWM $263 US futures red China tech red Europe red $VIX [--] Euro/$ [----] $SPY $694 $nasdaq 23.7k $XBI $126 #Bitcoin $82836 $ETH $2.745 $SOL [---] $SPX $QQQ https://twitter.com/i/web/status/2017155312411713617 https://twitter.com/i/web/status/2017155312411713617"  
[X Link](https://x.com/BehaviorFin/status/2017155312411713617) [@BehaviorFin](/creator/x/BehaviorFin) 2026-01-30T08:37Z [----] followers, [---] engagements


"970-uncertainty Fed head change $BTC $83k Gold.Silver.Copper.Natgas. Bitcoin crash 4.27% US 10y rate Euro/$ [----] Gold [----] UP WtiOil [--] SLV [---] Copper [----] $IWM $263 US futures red China tech red Europe red $VIX [--] Euro/$ [----] $SPY $694 $nasdaq 23.7k $XBI $126 #Bitcoin $82836 $ETH $2.745 $SOL [---] $SPX $QQQ https://twitter.com/i/web/status/2017151949989097840 https://twitter.com/i/web/status/2017151949989097840"  
[X Link](https://x.com/BehaviorFin/status/2017151949989097840) [@BehaviorFin](/creator/x/BehaviorFin) 2026-01-30T08:24Z [----] followers, [---] engagements


"$XBI China's CSPC Pharmaceutical signs deal with $AZN AstraZeneca for weight-loss therapy $LLY $NVO $GPCR $VKTX $MRK $ABBV https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharmaceutical-inks-deal-with-astrazeneca-weight-loss-therapy-2026-01-30/ https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-cspc-pharmaceutical-inks-deal-with-astrazeneca-weight-loss-therapy-2026-01-30/"  
[X Link](https://x.com/WallStSai/status/2017119907209507066) [@WallStSai](/creator/x/WallStSai) 2026-01-30T06:17Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing